APA (7th ed.) Citation

I, A., HY, K., SF, B., N, G., MH, U., M, N., . . . AS, A. (2025). Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations. JCO oncology advances, 2(1), e2400032. https://doi.org/10.1200/OA-24-00032

Chicago Style (17th ed.) Citation

I, Azar, et al. "Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations." JCO Oncology Advances 2, no. 1 (2025): e2400032. https://doi.org/10.1200/OA-24-00032.

MLA (9th ed.) Citation

I, Azar, et al. "Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations." JCO Oncology Advances, vol. 2, no. 1, 2025, p. e2400032, https://doi.org/10.1200/OA-24-00032.